ARISTOTELES at the AFFIRMO Final Conference to Discuss the Future of AI and Personalised Healthcare
- 11 September 2026
On 8 September 2026, the ARISTOTELES project took part in the AFFIRMO Final Conference, held in Copenhagen, Denmark, bringing together researchers, clinicians, policymakers, and patient representatives to discuss the future of integrated and personalised healthcare.
The event opened with remarks from Tom Lüscher, representing the European Society of Cardiology (ESC), and Tomislav Sokol, representing the European Parliament.
Davide Antonio Mei, cardiologist and researcher at the Università degli Studi di Modena e Reggio Emilia, represented ARISTOTELES in a panel discussion on the future of clinical guidelines and patient care pathways, moderated by Prof. Søren Paaske Johnsen.
The discussion brought together representatives of several European research initiatives, including Riccardo Proietti from DORIAN GRAY, Sandra Ortega-Martorell and Mattias Ohlsson from TARGET, alongside Alexandru Costescu and Martin Asteizan from the European Commission. Trudie Lobban, representing the Arrhytmia Alliance, contributed the patient perspective.
Connecting European initiatives for better patient care
The panel provided an opportunity to exchange perspectives on how artificial intelligence (AI) can support the evolution of healthcare, contributing to more effective clinical decision-making, personalised treatment strategies, and care pathways that better reflect individual patient needs.
These discussions closely align with the mission of ARISTOTELES, which aims to leverage harmonised health data and advanced AI approaches to predict adverse health outcomes and the development or worsening of comorbidities. By supporting earlier risk identification and more personalised approaches to disease management, the project contributes to the broader effort to make healthcare more proactive, effective, and patient-centred.
Keeping patients at the centre of AI innovation
A key message emerging from the discussion was that technological innovation should serve patients and healthcare professionals. AI has the potential to support clinical practice and improve the personalisation of care, but its implementation must remain guided by patients’ individual needs and preferences.
Participation in the AFFIRMO Final Conference reaffirmed the importance of collaboration among European research projects in advancing responsible AI in healthcare and translating scientific progress into meaningful benefits for patients.
Through its engagement with fellow European initiatives, ARISTOTELES continues to contribute to the dialogue on how AI can help shape the future of personalised, integrated, and patient-centred healthcare.
Read more about the AFFIRMO on the project website.